جست‌وجوی استاد و پژوهشگر

• Epigenetics
• Cardiovascular Disease
• Metabolic Disease
• +۵ مورد دیگر

Bradley Ferguson serves as Associate Professor and Graduate Program Director in the Department of Molecular Biosciences at the University of Nevada, Reno. His research bridges metabolic disease and cardiovascular pathology through epigenetic mechanisms, with a focus on translating basic discoveries into therapies for cardio-metabolic disorders. His academic background includes: B.S. from Appalachian State University (2003) M.S. from University of North Carolina, Greensboro (2005) Ph.D. from University of North Carolina, Greensboro (2011) Ferguson's laboratory investigates how histone modifications—particularly acetylation/deacetylation—regulate gene expression during obesity- and diabetes-induced cardiac hypertrophy and fibrosis. Using integrative approaches spanning bioinformatics, cell culture, and animal models, his team examines dietary components as epigenetic modifiers and their therapeutic potential. The lab emphasizes teamwork to accelerate the translation of molecular insights into clinical applications for heart failure. Analysis of his 2022-2025 publications reveals dominant themes in HDAC-mediated cardiac/skeletal muscle pathology, dietary epigenetics (e.g., emodin as an HDAC inhibitor), and gut-heart axis interactions. His work consistently links molecular mechanisms like PKC phosphorylation and ACTA1 acetylation to translational outcomes in metabolic syndrome and heart failure. No scientific awards were documented in the provided materials. As Graduate Program Director, Ferguson oversees academic training while leading a collaborative lab environment focused on cardio-metabolic disease research. Although specific grant details are unreported, his publication volume indicates sustained funding supporting bioinformatics, in vitro, and in vivo methodologies. His research group employs a multidisciplinary team to dissect epigenetic signaling in cardiac remodeling, utilizing translational models to explore dietary interventions and microbiome interactions. The lab culture prioritizes camaraderie to drive discoveries from bench to bedside for metabolic disease therapeutics.

• Atherosclerosis regression mechanisms
• Cardiovascular pharmacology
• Diabetes macrovascular complications
• +۴ مورد دیگر

Professor Orina Belton is a distinguished academic at University College Dublin (UCD), where she serves as Professor of Pharmacology in the School of Biomolecular and Biomedical Science. She has held this position since 2018, following progressive academic appointments at UCD including Associate Professor (2016-2018), Senior Lecturer (2014-2016), and Lecturer (2007-2013) in Pharmacology. Her research is conducted through the Conway Institute at UCD's Belfield campus in Dublin 4. Dr. Belton's educational background includes a BSc from NUI Galway and a PhD from University College Dublin. Her academic journey began with postgraduate studies at the Royal College of Surgeons in Ireland (RCSI) from 1995-1999, followed by postdoctoral research at RCSI from 1999-2003. Professor Belton's research program focuses on two primary areas of cardiovascular disease. Her main research interest investigates the fundamental mechanisms governing atherosclerosis regression, utilizing a novel model involving conjugated linoleic acid (CLA) in apoE knockout mice. She employs comprehensive "omic" approaches to identify key genes and pathways involved in plaque regression. Her secondary research area examines macrovascular complications of diabetes, particularly how hypoglycemic drugs affect cardiovascular disease progression in type 2 diabetes patients. This work combines clinical data with molecular analysis of patient plaques and human macrophages. Analysis of Professor Belton's recent publications reveals a strong focus on inflammation resolution in cardiovascular disease, with particular emphasis on macrophage biology, microRNA regulation, and novel therapeutic approaches for atherosclerosis. Her work demonstrates increasing sophistication in molecular techniques, moving from phenotypic observations to network analysis and identification of central regulatory genes. The research bridges basic science with clinical applications, often utilizing both murine models and human tissue samples to validate findings. SMMS Teacher of the Year Award (2015) SMMS Teacher of the Year Award (2014) SMMS Teacher of the Year Award (2011) Professor Belton actively supervises PhD students and has coordinated numerous advanced pharmacology modules including Research Skills, Research Techniques, Advanced Cardiovascular Pharmacology, and Drug Action in Body Systems. Her research has been supported by multiple funding agencies including Science Foundation Ireland, Enterprise Ireland, Health Research Board, European Federation for the Study of Diabetes, and Wellcome Trust. Current and past grants include work on macrophage accumulation in adipose tissue and the Functional Food Centre project. Her laboratory work centers on mechanisms of atherosclerosis regression, with particular focus on how conjugated linoleic acid modulates monocyte/macrophage function. The research team employs a range of techniques from in vivo models to cellular and molecular analysis, including proteomics, RNA-seq, and functional assays examining monocyte-endothelial interactions, integrin regulation, adhesion, migration, and foam cell formation.

• Angiogenesis
• Retinopathy
• Cancer Research
• +۶ مورد دیگر

Dr. Pierre Hardy is a Full Professor in the Faculty of Medicine at the University of Montreal, holding dual appointments in the Department of Pediatrics and the Department of Pharmacology and Physiology. He is affiliated with CHU Sainte-Justine Research Center and the Vision Health Research Network. His research focuses on cell-derived microvesicles, particularly lymphocyte microparticles, and their therapeutic applications in cancer treatment and eye diseases. Medical degree from Université Laval (1979-1984) Specialization in Pediatrics/Neonatology from McGill University (1985-1994) PhD in Pharmacology from Université de Montréal (1995-2000) Postdoctoral fellowship at University of Philadelphia Institute of Medicine and Biomedical Engineering (2000-2002) Dr. Hardy's research explores how lymphocyte-derived microparticles (LMPs) can inhibit tumor growth and pathological angiogenesis. His work demonstrates that LMPs can reduce tumor growth by 70% in mouse models and shows promise for treating retinopathy of prematurity and age-related macular degeneration. His innovative approach could potentially reduce chemotherapy side effects by preventing cancer cell proliferation between treatments, allowing for less aggressive chemotherapy regimens. His most recent publications focus on lipid nanoparticles for miRNA delivery in glioblastoma treatment, lymphocytic microparticles' modulation of macrophage angiogenic properties, and microRNA signatures in age-related macular degeneration. These works span disciplines including nanotechnology, ophthalmology, oncology, and immunology, with particular emphasis on therapeutic applications of cell-derived vesicles. Chercheur-boursier Junior 1, Fonds de la recherche en santé du Québec (2002-2006) Postdoctoral research grant, Canadian Institutes of Health Research (1999-2002) Research on age-related macular degeneration, FRQS (2015-2016) Dr. Hardy has successfully mentored numerous graduate students through their M.Sc. and Ph.D. programs, with recent theses focusing on lipid nanoparticle systems for miR-34a-5p delivery in retinoblastoma treatment and investigation of microRNA Let-7f in retinal pigment epithelial cell degeneration. His research is supported by multiple grants from CIHR, FRQS, NSERC, and the Charles Bruneau Foundation, totaling over $2 million in active funding for projects spanning 2020-2028. His laboratory at CHU Sainte-Justine focuses on translating basic discoveries about microparticles into potential clinical applications for cancer and eye diseases.

• Nutritional Science
• Food Biotechnology
• Human Nutrition
• +۵ مورد دیگر

Dr. J Bruce German is a Professor in the Department of Food Science and Human Nutrition at the University of Illinois at Urbana-Champaign. A leading researcher in nutritional science, his work spans food biotechnology, glycomics, immunology, and wearable technology applications for dietary monitoring. He has made significant contributions to understanding milk microRNAs, microbial immune imprinting, and plant glycomic mapping. His recent publications focus on the intersection of microbiology, lipidomics, and nutritional technology. Notably, he has explored bifidobacteria's role in early immune development and innovative methods for polysaccharide analysis. Despite no explicit awards listed, his editorial roles indicate leadership in nutrition research.

• DNA Repair
• Cancer Biology
• Molecular Biology
• +۵ مورد دیگر

Hailiang Hu is a tenure-track Associate Professor at Southern University of Science and Technology's School of Medicine. He holds a PhD in Biochemistry & Molecular Biology from Chinese Academy of Sciences and completed postdoctoral training at UCLA. His career includes roles at Duke University (Assistant Professor) and UCLA (Assistant Researcher/RAP) with grants from NIH, DoD, and California-based programs. Education : BS in Chemistry (Nankai University) and PhD in Biochemistry & Molecular Biology (CAS) Research Focus : DNA repair mechanisms, tumor metabolism reprogramming, and non-coding RNA roles in therapy-resistant GU cancers. His prostate cancer work explores castration resistance and neuroendocrine trans-differentiation, while iPSC studies address Ataxia-Telangiectasia neurodegeneration. Current projects target biomarker discovery and radiosensitizer development. Publication Trends : 15-year span shows concentration on miRNA/DNA repair (2000-2017), prostate cancer metabolism (2010-2021), and therapy resistance mechanisms (2005-2021). Key journals include PNAS, Nature Communications, and Molecular Cancer. Scientific Awards : PCF Movember Valor Challenge Award (2018) California BCRP IDEA Award (2011) UCLA Postdoctoral Excellence Award (2006) JCCF Postdoctoral Fellowship (2003) Proctor & Gamble Baojie Award (2000) Advisory Roles : Guest Editor at Frontier in Pharmacology and peer reviewer for 15+ journals including Clinical Cancer Research and DNA Repair. Labs & Collaborations : Leads research at SUSTech's School of Medicine, with prior affiliations at Duke Pathology Department and UCLA's Jonsson Cancer Center.

Molly Megrawمشاهده پروفایل

دانشیار

• Transcription Factors
• Machine Learning
• Arabidopsis
• +۶ مورد دیگر

Molly Megraw is an Associate Professor at Oregon State University's College of Agricultural Sciences , affiliated with the Department of Botany and Plant Pathology , Molecular and Cellular Biology Program , and Center for Genome Research and Biocomputing . She also collaborates with the Department of Electrical Engineering and Computer Science. Education : Ph.D. in Bioinformatics (2007) from the University of Pennsylvania Her research integrates computational biology , machine learning , and plant genomics to study: Transcriptional regulation of Pol-II genes and miRNAs in plants Network motif analysis in TF-miRNA circuits Chromatin accessibility and promoter identification via nanoCAGE Synthetic biology applications in plant systems Recent publications focus on: Salinity stress responses in rice miRNA editing in human cancer Network motif discovery algorithms PlantSimLab modeling platform Scientific accomplishments include: NSF CAREER Award (2018) for machine learning models of gene regulation MiRGen database development for miRNA genomic organization She supervises graduate students in Biological and Physical Sciences (BPP) and teaches computational courses like BDS 470/570 Introduction to Computing in the Life Sciences . Her lab maintains active collaborations across plant biology and computational disciplines.

Angus M. MacNicolمشاهده پروفایل

استاد

• Control of cell fate
• Post-transcriptional control of gene expression
• Stem cells and cancer stem cells
• +۷ مورد دیگر

Angus M. MacNicol is a Professor and Vice Chair in the Department of Neuroscience at the University of Arkansas for Medical Sciences (UAMS) College of Medicine. His research focuses on the molecular mechanisms underlying cellular plasticity in the anterior pituitary gland, post-transcriptional gene regulation, and the role of stem cells in tissue regeneration and disease. Education: Ph.D. from the National Institute for Medical Research/King’s College London, U.K.; Postdoctoral training at Stanford University and the University of California, San Francisco. Research Interests include: Regulation of anterior pituitary cellular plasticity through Sox2-expressing stem cells and transdifferentiation of hormone-producing cells. Post-transcriptional control via microRNAs (miRNAs) and RNA-binding proteins like ELAVL1 and Musashi (MSI), which modulate gonadotrope function and hormone secretion. Investigating the Musashi protein family's dual role in translational repression and activation, particularly in pituitary stem/progenitor cell differentiation and cancer stem cell functionality. Methodologies employed in his work include single-cell RNA sequencing, proteogenomics, 3D organoid cultures, mass spectrometry, and bioinformatics. His research is funded by the NIH. Mentoring & Service: Dr. MacNicol has mentored numerous students and junior faculty, including 9 PhD graduates and 7 postdoctoral fellows. He has served as Vice Chair of the Department of Neuroscience since 2019, participates in faculty development committees, and lectures in UAMS core courses. He also contributes to editorial boards and grant review panels for organizations like the NIH and Welcome Trust. Labs & Collaborations: Collaborates with Dr. Gwen Childs, Dr. Melanie MacNicol, and Dr. Angela Odle at UAMS. His team utilizes mouse models, Xenopus, and human iPSCs to study mRNA regulatory networks in pituitary plasticity and disease.

Madhvi Menonمشاهده پروفایل

پژوهشگر ارشد

• Immunology
• Respiratory Diseases
• Autoimmunity
• +۲ مورد دیگر

Dr. Madhvi Menon is a UKRI Future Leaders Fellow at the University of Manchester, affiliated with the Division of Immunology, Immunity to Infection and Respiratory Medicine. Her research focuses on B cell interactions in chronic respiratory diseases and autoimmunity, with a specific emphasis on COPD, autoantibody mechanisms, and interferon signaling pathways. Education: PhD in Immunology from University College London (2015) Postdoctoral Training: Harvard Medical School (age-related macular degeneration research), University College London (rheumatoid arthritis pathogenesis) Research trends include inflammatory pathway analysis in autoimmune disorders, miRNA/cytokine profiling in viral infections, and monocyte migration dynamics in acute/long COVID-19. Key subfields span autoantibody functionality, interferon isoform interactions, and spatially-resolved omics applications. Scientific Award: UKRI Future Leaders Fellowship Currently supervises three PhD students (Holly Sedgwick, Maana Layeghi, Rebecca Rowan) and collaborates on multi-institutional projects like 'Laser capture dissection for spatially-resolved -omics analysis.'

Kimberly Maceمشاهده پروفایل

مدرس ارشد

• Regenerative Medicine
• Wound Healing
• Myeloid Cell Biology
• +۷ مورد دیگر

Kimberly Mace is a Senior Lecturer in the Division of Cell Matrix Biology & Regenerative Medicine at the Faculty of Biology, Medicine and Health, University of Manchester, UK. She has held academic positions since 2012, focusing on tissue repair and regeneration, with a particular emphasis on myeloid cell biology and transcriptional regulation during wound healing. Her work intersects with the Manchester Regenerative Medicine Network, Lydia Becker Institute, and Christabel Pankhurst Institute. PhD, University of California San Diego (1997-2003) BSc, University of Nevada Las Vegas (1992-1996) BFA, University of Southern California (1986-1991) Mace's research investigates how myeloid cells regulate wound repair and regeneration in diabetic and aging contexts. Her lab uses mouse models to analyze: Myeloid cell recruitment to injured tissues Transcriptional and epigenetic mechanisms in inflammation Role of iron metabolism in healing Therapeutic strategies like electrical stimulation and collagen dressings Key article trends include myeloid cell dysfunction in diabetes, electrical stimulation for tissue repair, and epigenetic regulation of inflammation. Her work contributes to UN Sustainable Development Goals via regenerative medicine advancements. Scientific Awards: Healing Foundation Fellow (2007-2012) Ruth L. Kirschstein NIH Postdoctoral Fellow (2003-2007)

Surya Nauliمشاهده پروفایل

استاد

• Cilia Biology
• Cardiovascular Disease
• Polycystic Kidney Disease
• +۳ مورد دیگر

Surya Nauli is a Professor at Chapman University School of Pharmacy and holds an affiliation with the University of California, Irvine . He earned a PhD in Pharmacology from Loma Linda University and completed an NIH fellowship at Harvard Medical School before joining Chapman in 2014. Current research focuses on Cilia Biology , Cardiovascular Disease , and Polycystic Kidney Disease . Techniques include Calcium Signaling , Chemical Screening , and In Vivo Therapy for ciliary modulation. Recent publications span 2025 to 2021 , with emphasis on 2025 studies in Proteomics and Calcium Signaling . Earlier works explore 2024 topics like Anti-inflammatory Agents and MiRNA Roles , followed by 2023 contributions on Nanomedicine and Metabolomics . Scientific Awards : NIH Fellowship Key collaborations include institutions such as Harvard Medical School, University of Toledo, and UC Irvine. His lab website at Chapman Cilia Lab details projects on Ciliopathy and Ciliotherapy , integrating Nanotechnology with Cardiovascular Research .

• Biomedical Science
• Cancer Biology
• RNA Biology
• +۳ مورد دیگر

Dr. Chinedu Anene is a Senior Lecturer at the School of Health, Leeds Beckett University, with a research focus on biomedical science. He is affiliated with the Centre for Biomedical Science Research, contributing to fields such as cancer biology, RNA regulation, and tumor microenvironment studies. His research spans molecular oncology, including metastasis mechanisms in melanoma and esophageal squamous cell carcinoma, RNA biology involving enhancer RNAs and RNA-binding proteins, and cellular signaling pathways like the Hippo pathway in cervical cancer. His recent work explores viral RNA processing, platelet-derived extracellular vesicles in cancer progression, and transcriptomic biomarkers for prognosis. Publications highlight interdisciplinary approaches combining genomics, bioinformatics, and clinical applications. Key themes include noncoding RNA interactions, miRNA profiling in diabetes-related breast cancer, and host-virus dynamics.

Baohong Zhaoمشاهده پروفایل

استاد

• Bone biology
• Osteoclastogenesis
• Inflammatory signaling
• +۳ مورد دیگر

Baohong Zhao, MD, PhD, is Professor of Biochemistry in Medicine at Weill Cornell Medical College (2024–present). She earned her DMD (2001) and BM (1999) from Peking University and her PhD from Showa University Graduate School, Japan (2008). Her research focuses on molecular mechanisms governing bone homeostasis, osteoclastogenesis, and inflammatory signaling in skeletal and immunological contexts. Education Ph.D. — Showa University Graduate School (Japan), 2008 D.M.D. — Peking University (China), 2001 B.M. — Peking University Health Science Center (China), 1999 Research Interests Professor Zhao’s laboratory integrates bone biology, immunology, and epigenetics to dissect how osteoclasts and osteoblasts communicate with immune cells. Key themes include: Long non-coding RNA Malat1 as a master regulator of bone repair and β-catenin signaling Transcription factor RBP-J in macrophage polarization and osteoclast differentiation TGFβ and TNF crosstalk driving inflammatory bone resorption MicroRNA networks controlling osteoclastogenesis and skeletal remodeling Adipoq-lineage progenitors as critical sources of M-CSF in bone marrow niches Her work leverages conditional knockout mouse models, single-cell transcriptomics, and pharmacological inhibitors to translate findings into therapeutic targets for osteoporosis, Paget’s disease, and inflammatory arthritis. Publications Overview Since 2008, Professor Zhao has published >70 peer-reviewed articles, including high-impact studies in Nature Medicine , Nature Communications , Journal of Experimental Medicine , and Immunity . Recent work (2022-2025) highlights novel roles for lncRNAs, epigenetic regulators, and cytokine circuits in bone-immune interactions, collectively advancing understanding of skeletal diseases and identifying potential therapeutic avenues. Scientific Awards & Honors No specific awards are listed in the provided text. Advising & Funding No explicit information on current students or grant numbers is provided. Laboratory & Teams Professor Zhao leads an active research group at Weill Cornell Medical College, integrating molecular biology, immunology, and translational orthopedics to explore skeletal health and disease.

Dazhong Xuمشاهده پروفایل

دانشیار

• Cancer Biology
• Molecular Biology
• Environmental Toxicology
• +۵ مورد دیگر

Dazhong Xu, Ph.D. , is an Associate Professor at the School of Medicine, New York Medical College (NYMC) , where he joined in 2014 as Assistant Professor of Pathology and Head of the Flow Cytometry Core Laboratory. He served as Vice Chair of Research in the Department of Pathology from 2017 to 2021 and was promoted to Associate Professor of Pathology, Microbiology, and Immunology in 2020. Prior to NYMC, he worked at New York University School of Medicine as a Research Assistant Professor and at Tufts University School of Medicine as an Instructor of Medicine. Education: Ph.D. in Biomedical Sciences, Wright State University M.S. in Zoology, University of Florida B.S. in Biology, Nanjing University Postdoctoral Training: Massachusetts General Hospital/Harvard Medical School, Tufts Medical Center Dr. Xu's research focuses on the molecular and cellular biology of cancer , particularly lung carcinogenesis caused by environmental and occupational carcinogens. His lab aims to identify novel molecular mechanisms driving cancer initiation and progression using advanced tools like mouse models and genetic engineering , with applications in DNA damage response and chromatin modifications . His recent publications highlight studies on hexavalent chromium toxicity (2024), DNA polymerase regulation (2025), and adapter protein dynamics (2021-2023). These works span environmental toxicology , genomic instability , and immunomodulation . Honors & Awards: 2005 Jay N. Cohn New Investigator Award in Basic Science 2005 & 2004 Travel Awards, The Heart Failure Society of America 2002 National Research Service Award Individual Postdoctoral Fellowship Dr. Xu teaches Selected Topics in Cancer Biology and Introduction to Pathology at NYMC. His collaborations include researchers from Tufts, Harvard, and the Heart Failure Society of America, with grants emphasizing environmental carcinogenesis and cellular stress responses .

Xiwei Wuمشاهده پروفایل

استاد

• Computational Biology
• Bioinformatics
• Cancer Genomics
• +۳ مورد دیگر

Xiwei Wu, Ph.D. serves as Professor in the Department of Computational and Quantitative Medicine at Beckman Research Institute, City of Hope. His work bridges bioinformatics, cancer genomics, and epigenetics with clinical applications. Ph.D., Loma Linda University (2002), Microbiology & Molecular Genetics M.D., Tianjin Medical University (1997) Research focuses on epigenetic mechanisms in cancer , including DNA methylation, miRNA regulation, and genomic biomarkers for precision oncology. His team develops computational models for thyroid nodule management and leukemia stem cell targeting. Active grants include NIH/NCI Integrative Genomics and Bioinformatics Core (Core Director) and pending CIRM funding for Sex-based targeting of myeloid leukemia stem cells ($900,000 direct support). Selma Andrews Award (1999) Publications highlight applications of bioinformatics in cutaneous lymphoma , breast cancer , and graft-versus-host disease , with recent work on N(6)-methyladenosine regulation and CAR T-cell modifications.

• Molecular Biology
• Immunology
• Autoimmune Diseases
• +۴ مورد دیگر

Julia Maslovskaja is a molecular biologist and immunologist currently serving as Project Manager at Icosagen Cell Factory OÜ and as Research Fellow of Molecular Immunology at the University of Tartu, Faculty of Medicine, Institute of Biomedicine and Translational Medicine. Her career spans research positions in molecular biology, immunology, and biomedicine with a particular focus on autoimmune diseases and skin disorders. Education Doctor's Degree (2020): "The importance of DNA binding and DNA breaks for AIRE-mediated transcriptional activation" from University of Tartu, Faculty of Medicine, Institute of Biomedicine and Translational Medicine, supervised by Ana Rebane and Pärt Peterson Research Master's Degree (2007): "The autoimmune regulator protein participates in loop formation between epidermal differentiation complex gene family members" from University of Tartu, supervised by Pärt Peterson Research Interests Dr. Maslovskaja's research focuses on molecular mechanisms underlying autoimmune diseases, particularly involving the Autoimmune Regulator (AIRE) protein. Her work spans several interconnected areas: Molecular immunology of autoimmune disorders Role of microRNAs in skin inflammatory conditions like psoriasis and atopic dermatitis Mechanisms of AIRE-mediated transcriptional regulation in immune tolerance Genetic and epigenetic factors in autoimmune disease pathogenesis Immune responses in viral infections including SARS-CoV-2 Publication Trends Dr. Maslovskaja's publication record shows a consistent focus on molecular immunology with particular emphasis on autoimmune regulation mechanisms. Her work has evolved from fundamental studies of AIRE protein function to clinical implications in autoimmune diseases and inflammatory skin conditions. Over the past 15 years, she has established herself as a specialist in microRNA regulation in skin inflammation and AIRE-mediated immune tolerance mechanisms. Her recent work has also expanded to include research on immune responses in viral infections, particularly during the COVID-19 pandemic. Professional Activities Dr. Maslovskaja has held various research positions at the University of Tartu and Icosagen Cell Factory OÜ. She has also served as a Pharmacovigilance assessor at the State Agency of Medicines. Her work has involved collaboration with numerous international research groups studying autoimmune conditions and immune responses.